1: Nielsen D, Eriksen J, Maare C, Friche E, Skovsgaard T. Related Articles, Links
Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
Cancer Chemother Pharmacol. 2002 Jun;49(6):453-60.
PMID: 12107549 [PubMed - indexed for MEDLINE]
2: Plo I, Hernandez H, Kohlhagen G, Lautier D, Pommier Y, Laurent G. Related Articles, Links
Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cells.
J Biol Chem. 2002 Aug 30;277(35):31407-15.
PMID: 12105221 [PubMed - indexed for MEDLINE]
3: Lin H, Liu XY, Subramanian B, Nakeff A, Valeriote F, Chen BD. Related Articles, Links
Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination.
Int J Cancer. 2002 Jan 1;97(1):121-8.
PMID: 11774253 [PubMed - indexed for MEDLINE]
4: Dingemans AC, van Ark-Otte J, Span S, Scagliotti GV, van der Valk P, Postmus PE, Giaccone G. Related Articles, Links
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
Lung Cancer. 2001 May;32(2):117-28.
PMID: 11325482 [PubMed - indexed for MEDLINE]
5: Boland MP, Fitzgerald KA, O'Neill LA. Related Articles, Links
Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
J Biol Chem. 2000 Aug 18;275(33):25231-8.
PMID: 10940316 [PubMed - indexed for MEDLINE]
Time used: 78 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005